AG

Artal Group Portfolio holdings

AUM $930M
This Quarter Return
+7.02%
1 Year Return
-3.57%
3 Year Return
+157.23%
5 Year Return
+160.22%
10 Year Return
+1,359.85%
AUM
$5.38B
AUM Growth
+$336M
Cap. Flow
+$11.7M
Cap. Flow %
0.22%
Top 10 Hldgs %
92.84%
Holding
124
New
16
Increased
27
Reduced
16
Closed
13

Top Buys

1
ALNY icon
Alnylam Pharmaceuticals
ALNY
$25.4M
2
INCY icon
Incyte
INCY
$9.47M
3
ARGX icon
argenx
ARGX
$9.2M
4
AXDX
Accelerate Diagnostics
AXDX
$7.86M
5
DNLI icon
Denali Therapeutics
DNLI
$7.82M

Top Sells

1
NKTR icon
Nektar Therapeutics
NKTR
$50.8M
2
BMRN icon
BioMarin Pharmaceuticals
BMRN
$18.6M
3
SAGE
Sage Therapeutics
SAGE
$12.4M
4
NBIX icon
Neurocrine Biosciences
NBIX
$11.6M
5
RXDX
Ignyta, Inc.
RXDX
$11.1M

Sector Composition

1 Consumer Staples 53.33%
2 Consumer Discretionary 24.25%
3 Healthcare 21.69%
4 Financials 0%
5 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
FBRX icon
76
Forte Biosciences
FBRX
$138M
$1.03M 0.02%
+267
New +$1.03M
IBRX icon
77
ImmunityBio
IBRX
$2.24B
$1.01M 0.02%
225,000
– –
CLDX icon
78
Celldex Therapeutics
CLDX
$1.57B
$995K 0.02%
23,356
-21,644
-48% -$922K
CALA
79
DELISTED
Calithera Biosciences, Inc
CALA
$835K 0.01%
5,000
-3,750
-43% -$626K
NVLN
80
DELISTED
Novelion Therapeutics Inc. Common Shares
NVLN
$800K 0.01%
256,400
– –
IMDX
81
Insight Molecular Diagnostics Inc. Common Stock
IMDX
$73.3M
$698K 0.01%
7,500
– –
NVAX icon
82
Novavax
NVAX
$1.2B
$620K 0.01%
25,000
– –
XENE icon
83
Xenon Pharmaceuticals
XENE
$2.99B
$424K 0.01%
150,000
– –
AAL icon
84
American Airlines Group
AAL
$8.87B
– –
0
– –
AMGN icon
85
Amgen
AMGN
$153B
– –
0
– –
BABA icon
86
Alibaba
BABA
$325B
– –
0
– –
BAC icon
87
Bank of America
BAC
$371B
– –
0
– –
BHF icon
88
Brighthouse Financial
BHF
$2.55B
– –
0
– –
BLK icon
89
Blackrock
BLK
$170B
– –
0
– –
BMRN icon
90
BioMarin Pharmaceuticals
BMRN
$11.3B
– –
-200,000
Closed -$18.6M
BMY icon
91
Bristol-Myers Squibb
BMY
$96.7B
– –
0
– –
C icon
92
Citigroup
C
$175B
– –
0
– –
ELF icon
93
e.l.f. Beauty
ELF
$7.38B
– –
-200,000
Closed -$4.51M
FCX icon
94
Freeport-McMoran
FCX
$66.3B
– –
0
– –
FGEN icon
95
FibroGen
FGEN
$48.4M
– –
-2,000
Closed -$2.69M
GILD icon
96
Gilead Sciences
GILD
$140B
– –
0
– –
GS icon
97
Goldman Sachs
GS
$221B
– –
0
– –
IBM icon
98
IBM
IBM
$227B
– –
0
– –
INTC icon
99
Intel
INTC
$105B
– –
0
– –
MET icon
100
MetLife
MET
$53.6B
– –
0
– –
1 2 3
4
5